Preclinical model of ischemic tissue damage in the heart
Postischemic inflammatory damage of the myocardium and decline in cardiac function
Cross-priming dendritic cells and CD8+ T cells represent potential novel therapeutic targets to prevent postischemic immunopathology and heart failure.
Activation of cytotoxic CD8+ T cells by cross-priming DC contributes to exacerbation of postischemic inflammatory damage of the myocardium and corresponding decline in cardiac function. Importantly, this provides novel therapeutic targets to prevent postischemic immunopathology and heart failure.
Building similarity graph...
Analyzing shared references across papers
Loading...
Elvira Forte
Jackson Laboratory
Bryant Perkins
Amalia Sintou
Circulation
Amgen (United States)
Jackson Laboratory
Lung Institute
Building similarity graph...
Analyzing shared references across papers
Loading...
Forte et al. (Thu,) studied this question.
synapsesocial.com/papers/69d5718375589c71d767e299 — DOI: https://doi.org/10.1161/circulationaha.120.044581